Peer Review channel feed

Flag­ship keeps ex-FDA com­mish Stephen Hahn busy with an­oth­er CMO gig; Daphne Koller makes key hire at in­sitro by wel­com­ing Google and Face­book vet

4 years ago

Zio­pharm finds new CEO af­ter six-month search; CFO tran­si­tion at Lon­za to take place in De­cem­ber

4 years ago

As­traZeneca pro­motes on­col­o­gy ex­ec to CMO; Pfiz­er re­places re­tir­ing chief deal­mak­er as war chest ex­pands

4 years ago

No­vavax grabs an­oth­er CFO while Pat Cotro­neo re­tires from Fi­bro­Gen; Eli Lil­ly re­assem­bles key staff af­ter bio­med­i­cines unit split

4 years ago

Robert Baze­more makes Hutchmed deal his grand fi­nale as Epizyme CEO; Black Di­a­mond reshuf­fles the deck with de­par­tures of CMO, CSO

4 years ago

Ver­tex taps long­time com­mer­cial lead to fill two-year COO va­can­cy; Nan­cy Thorn­ber­ry set for dif­fer­ent role at Kally­ope with an old friend from Mer­ck wait­ing in the wings

4 years ago

Roche Chi­na CEO preps for a move to Mer­ck KGaA while US Mer­ck adds to C-suite; Suc­ces­sion plan fi­nal­ized for EVPs re­tir­ing from Sanofi

4 years ago

Jim Wil­son start­up Pas­sage Bio plugs in CFO, CMO; Till­man Gern­gross nabs a COO fa­mil­iar with Covid-19 fight at Pfiz­er as Ada­gio files for IPO

4 years ago

Eli Lil­ly part­ner Ab­Cellera finds a CBO in the face of bam­lanivimab strug­gles; Fi­bro­Gen's next CSO walks in­to rox­adu­s­tat re­buff

4 years ago

Great Danes: Two Nordic biotechs name their chief ex­ec­u­tives; Ax­el Hoos bids adieu to Glax­o­SmithK­line, be­comes CEO of small on­col­o­gy play­er

5 years ago

Cure­Vac gains COO and hands Flo­ri­an von der Mülbe new as­sign­ment in the midst of Covid-19 vac­cine trou­bles; As Ken Fra­zier re­tires, Mer­ck hires chief strat­e­gy of­fi­cer

5 years ago

With Glax­o­SmithK­line in the rearview mir­ror, Ab­bas Hus­sain is ready to lead a biotech of his own; Doug Tre­co scores first CEO job since Ra Phar­ma buy­out

5 years ago

Mod­er­na dips in­to J&J's tal­ent pool for Tal Zak­s' re­place­ment; Jim Mullen choos­es next chief sci­en­tist at Ed­i­tas Med­i­cine

5 years ago

In­ter­cept re­tools C-suite with a pair of new­com­ers; Charles Ryan moves past Alzheimer's flops with an­oth­er CEO chal­lenge

5 years ago

Two months af­ter ink­ing a SPAC deal, Ren­o­va­cor taps new CMO; Cure­Vac reels in a new de­vel­op­ment chief from Mer­ck KGaA

5 years ago

Re­cur­sion CSO heads west for mi­ni-brain up­start; No­var­tis vet steps up to the plate as CFO for An­drew Hirsch at C4 Ther­a­peu­tics

5 years ago

CFO tran­si­tion on the hori­zon at BioN­Tech as Sierk Po­et­ting con­cen­trates on COO du­ties; Centes­sa rides a wave of new ex­ecs af­ter An­toine Yver's ap­point­ment

5 years ago

As Co­di­ak en­ters 'next phase of growth,' Jen­nifer Whel­er steps in­to CMO role; Mark Tim­ney lines up his sec­ond CEO op­por­tu­ni­ty af­ter Pur­due Phar­ma reign

5 years ago

Karyopharm taps long­time Pfiz­er, Am­gen vet to steer the ship; With Mer­ck in the rearview mir­ror, Roger Perl­mut­ter stakes his claim to a CEO job — and it's a sur­pris­ing choice

5 years ago

Genen­tech alum Jane Gro­gan goes start­up hop­ping from Ar­se­nal­Bio to Graphite Bio; Scott Holmes to han­dle CFO du­ties at Cata­ma­ran Bio, team­ing up again with ex-Dis­arm CEO

5 years ago

A pair of Bay­er ex­ecs land pro­mo­tions in the US; En­er­gized by lenzilum­ab da­ta, Hu­mani­gen taps As­traZeneca alum as CMO

5 years ago

No­vavax CFO Greg Covi­no makes a quick ex­it as lead­er­ship carousel keeps turn­ing; Kite ex­ecs fly away to a cell ther­a­py up­start team­ing up with Lyell

5 years ago

John Robin­son re­cruits a small band of Ar­ray vets to kick­start dis­cov­ery at Co­gent; Syn­tim­mune co-founder takes charge at Arch On­col­o­gy

5 years ago

Cut­ting loose from Mer­ck, Mike Nal­ly is 'run­ning to­ward a great op­por­tu­ni­ty'; No­var­tis part­ner­ship in hand, BeiGene pro­motes Ju­lia Wang to CFO

5 years ago
First page Previous page 6789101112 Next page Last page
A service from the Financial Times